TSBK
TIMBERLAND BANCORP INC
$41.38
-0.50%
$323.9M
No data for this timeframe.
Vol
Market Cap$323.9M
Cap SizeSmall Cap
Inst. Holders7 funds
Inst. Value$25.9M
Inst. Activity2 buys / 0 sells
Insider Activity0B / 7S
Insider Net $-$529.6K
SEC Reports2
Exchange Nasdaq·Sector Savings Institutions, Not Federally Chartered·Inc. WA·CIK 0001046050·Prev Close $41.59
Recent Activity
Apr 30, 2026
SEC
Timberland Bancorp reported Q2 fiscal 2026 net income of $7.13M ($0.90 EPS), up 6% YoY from $6.76M ($0.85 EPS). However,
8-K — Impact 5/10
Apr 28, 2026
SEC
Timberland Bancorp reported Q2 fiscal 2026 net income of $7.13M ($0.90 diluted EPS), up 6% YoY but down 13% from the pri
PRESS-RELEASE — Impact 4/10
Feb 6, 2026
Insider
Antich Breanne D sold 400 shares
Chief Technology Officer/EVP @ $0.00 ($0.00)
Feb 6, 2026
Insider
Antich Breanne D sold 800 shares
Chief Technology Officer/EVP @ $40.05 ($32.0K)
Feb 6, 2026
Insider
Antich Breanne D sold 400 shares
Chief Technology Officer/EVP @ $28.23 ($11.3K)
Inst.
WELLS FARGO & COMPANY/MN — ADD
11,281 shares ($403.9K)
Inst.
FMR LLC — ADD
7,688 shares ($275.2K)
Apr 28, 2026
earnings
Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
<p>HOQUIAM, Wash., April 28, 2026 (GLOBE NEWSWIRE) -- Timberland Bancorp, Inc. (NASDAQ: TSBK) (“Ti
Analyst Ratings
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 16, 2012 | Raymond James | UPGRADE | Market Perform → Outperform |
Latest Reports
MIXED
8-K
5/10
Timberland Bancorp reported Q2 fiscal 2026 net income of $7.13M ($0.90 EPS), up 6% YoY from $6.76M ($0.85 EPS). However,
Apr 30, 2026
MIXED
PRESS-RELEASE
4/10
Timberland Bancorp reported Q2 fiscal 2026 net income of $7.13M ($0.90 diluted EPS), up 6% YoY but down 13% from the pri
Apr 28, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $15.0M | — |
| RENAISSANCE TECHNOLOGIES LLC | $7.8M | — |
| MORGAN STANLEY | $947.4K | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $801.3K | NEW |
| BANK OF AMERICA CORP | $679.5K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Feb 6, 2026 | Antich Breanne | M | $0.00 |
| Feb 6, 2026 | Antich Breanne | SELL | $32.0K |
| Feb 6, 2026 | Antich Breanne | M | $11.3K |
| Feb 5, 2026 | Fischer Jonathan | M | $31.3K |
| Feb 5, 2026 | Fischer Jonathan | SELL | $79.0K |
7 institutional holders with $25.9M total value (724,455 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, MORGAN. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 419,569 | $15.0M | 57.9% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 218,089 | $7.8M | 30.1% | — |
| 3 | MORGAN STANLEY | 26,463 | $947.4K | 3.7% | TRIM -26.8% |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 22,384 | $801.3K | 3.1% | NEW |
| 5 | BANK OF AMERICA CORP /DE/ | 18,981 | $679.5K | 2.6% | — |
| 6 | WELLS FARGO & COMPANY/MN | 11,281 | $403.9K | 1.6% | ADD +30.6% |
| 7 | FMR LLC | 7,688 | $275.2K | 1.1% | ADD +37.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | ADD | 8,639 | 11,281 | +30.6% | $403.9K | 2025-Q4 |
| FMR LLC | ADD | 5,586 | 7,688 | +37.6% | $275.2K | 2025-Q4 |
| UBS Group AG | DOUBLED | 2,988 | 8,263 | +176.5% | $275.0K | 2025-Q3 |
| UBS Group AG | TRIM | 4,551 | 2,988 | -34.3% | $93.2K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 27,367 | 20,037 | -26.8% | $604.1K | 2025-Q1 |
| FMR LLC | ADD | 4,323 | 5,821 | +34.7% | $175.5K | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 7,214 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | NEW | — | 9,381 | — | $286.2K | 2024-Q4 |
| UBS Group AG | ADD | 3,565 | 5,298 | +48.6% | $161.6K | 2024-Q4 |
| MORGAN STANLEY | ADD | 17,348 | 30,330 | +74.8% | $917.8K | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 22,434 | — | $678.9K | 2024-Q3 |
5 unique insiders with 7 transactions. Net insider value: -$529.6K ($0.00 bought, $529.6K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Antich Breanne D | Chief Technology Officer/EVP | M | 400 | $0.00 | $0.00 |
| Feb 6, 2026 | Antich Breanne D | Chief Technology Officer/EVP | SELL | 800 | $40.05 | $32.0K |
| Feb 6, 2026 | Antich Breanne D | Chief Technology Officer/EVP | M | 400 | $28.23 | $11.3K |
| Feb 5, 2026 | Fischer Jonathan Arthur | President/COO | M | 2,000 | $15.67 | $31.3K |
| Feb 5, 2026 | Fischer Jonathan Arthur | President/COO | SELL | 2,000 | $39.50 | $79.0K |
| Feb 5, 2026 | Fischer Jonathan Arthur | President/COO | M | 2,000 | $0.00 | $0.00 |
| Feb 5, 2026 | BASICH MARCI A | Chief Financial Officer/EVP | M | 477 | $28.23 | $13.5K |
| Feb 5, 2026 | BASICH MARCI A | Chief Financial Officer/EVP | SELL | 477 | $39.50 | $18.8K |
| Feb 5, 2026 | BASICH MARCI A | Chief Financial Officer/EVP | M | 477 | $0.00 | $0.00 |
| Feb 3, 2026 | BASICH MARCI A | Chief Financial Officer/EVP | M | 376 | $0.00 | $0.00 |
| Feb 3, 2026 | BASICH MARCI A | Chief Financial Officer/EVP | SELL | 376 | $39.50 | $14.9K |
| Feb 3, 2026 | BASICH MARCI A | Chief Financial Officer/EVP | M | 376 | $28.23 | $10.6K |
| Feb 2, 2026 | BASICH MARCI A | Chief Financial Officer/EVP | M | 2,000 | $0.00 | $0.00 |
| Feb 2, 2026 | BASICH MARCI A | Chief Financial Officer/EVP | M | 2,000 | $29.69 | $59.4K |
| Feb 2, 2026 | BASICH MARCI A | Chief Financial Officer/EVP | SELL | 4,347 | $39.52 | $171.8K |
| Feb 2, 2026 | DeBord Matthew J | Chief Lending Officer, EVP | M | 1,005 | $16.87 | $17.0K |
| Feb 2, 2026 | DeBord Matthew J | Chief Lending Officer, EVP | SELL | 3,805 | $39.53 | $150.4K |
| Feb 2, 2026 | DeBord Matthew J | Chief Lending Officer, EVP | M | 1,005 | $0.00 | $0.00 |
| Jan 30, 2026 | CLINTON ANDREA M | Director | M | 200 | $16.87 | $3.4K |
| Jan 30, 2026 | CLINTON ANDREA M | Director | SELL | 1,600 | $39.19 | $62.7K |
| Jan 30, 2026 | CLINTON ANDREA M | Director | M | 200 | $0.00 | $0.00 |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 2 mixed, 0 neutral. Avg impact: 4.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2015-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2015-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
1 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 16, 2012 | Raymond James | UPGRADE | Market Perform | Outperform |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 23, 2026
Clinical Trial
A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis
Phase Phase 2 — COMPLETED
May 23, 2026
Clinical Trial
The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis
Phase Phase 3 — COMPLETED
Apr 28, 2026
earnings
Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
<p>HOQUIAM, Wash., April 28, 2026 (GLOBE NEWSWIRE) -- Timberland Bancorp, Inc. (NASDAQ: TSBK) (“Timberland” or “the Company”), the holding company f
Apr 28, 2026
earnings_calendar
TSBK Q2 2026 Earnings Scheduled — 2026-04-28
Apr 20, 2026
earnings_calendar
TSBK Q2 2026 Earnings Scheduled — 2026-04-20